DelRicht Research | New Orleans, LA
Status and phase
Conditions
Treatments
About
This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants are eligible to be included in the study only if all of the following criteria apply:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
136 participants in 4 patient groups
Loading...
Central trial contact
Incyte Corporation Call Center (ex-US); Incyte Corporation Call Center (US)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal